Your browser doesn't support javascript.
loading
Diet quality indices and changes in cognition during chemotherapy.
Crowder, Sylvia L; Welniak, Taylor L; Hoogland, Aasha I; Small, Brent J; Rodriguez, Yvelise; Carpenter, Kristen M; Fischer, Stacy M; Li, Daneng; Kinney, Anita Y; Rotroff, Daniel; Mariam, Arshiya; Brownstein, Naomi; Reich, Richard R; Hembree, Tim; Playdon, Mary C; Arthur, Anna E; Vieytes, Christian AMaino; Li, Zonggui; Extermann, Martine; Kim, Richard; Berry, Donna L; Jim, Heather S L.
Afiliación
  • Crowder SL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
  • Welniak TL; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
  • Hoogland AI; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
  • Small BJ; School of Aging Studies, University of South Florida, Tampa, FL, USA.
  • Rodriguez Y; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
  • Carpenter KM; Department of Psychiatry, The Ohio State University, Columbus, OH, USA.
  • Fischer SM; Department of General Internal Medicine, University of Colorado Denver, Denver, CO, USA.
  • Li D; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Kinney AY; Department of Biostatistics and Epidemiology, School of Public Health, Rutgers University, New Brunswick, NJ, USA.
  • Rotroff D; Department of Quantitative Health Sciences, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA.
  • Mariam A; Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Endocrinology and Metabolism Institute, Cleveland, OH, USA.
  • Brownstein N; Department of Quantitative Health Sciences, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA.
  • Reich RR; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Hembree T; Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
  • Playdon MC; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Arthur AE; Department of Internal and Hospital Medicine, Moffitt Cancer Center, Tampa, FL, USA.
  • Vieytes CA; Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Li Z; Department of Nutrition and Integrative Physiology, University of Utah, Salt Lake City, UT, USA.
  • Extermann M; Department of Dietetics and Nutrition, Medical Center, University of Kansas, Kansas City, KS, USA.
  • Kim R; Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, Champaign, IL, USA.
  • Berry DL; Department of Psychology and Neuroscience, Boston College, Newtown, MA, USA.
  • Jim HSL; Department of Senior Adult Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Support Care Cancer ; 31(1): 75, 2022 Dec 22.
Article en En | MEDLINE | ID: mdl-36544032
PURPOSE: No evidence-based prevention strategies currently exist for cancer-related cognitive decline (CRCD). Although patients are often advised to engage in healthy lifestyle activities (e.g., nutritious diet), little is known about the impact of diet on preventing CRCD. This secondary analysis evaluated the association of pre-treatment diet quality indices on change in self-reported cognition during chemotherapy. METHODS: Study participants (n = 96) completed the Block Brief Food Frequency Questionnaire (FFQ) before receiving their first infusion and the PROMIS cognitive function and cognitive abilities questionnaires before infusion and again 5 days later (i.e., when symptoms were expected to be their worst). Diet quality indices included the Dietary Approaches to Stop Hypertension (DASH), Alternate Mediterranean Diet (aMED), and a low carbohydrate diet index and their components. Descriptive statistics were generated for demographic and clinical variables and diet indices. Residualized change models were computed to examine whether diet was associated with change in cognitive function and cognitive abilities, controlling for age, sex, cancer type, treatment type, depression, and fatigue. RESULTS: Study participants had a mean age of 59 ± 10.8 years and 69% were female. Although total diet index scores did not predict change in cognitive function or cognitive abilities, higher pre-treatment ratio of aMED monounsaturated/saturated fat was associated with less decline in cognitive function and cognitive abilities at 5-day post-infusion (P ≤ .001). CONCLUSIONS: Higher pre-treatment ratio of monounsaturated/saturated fat intake was associated with less CRCD early in chemotherapy. Results suggest greater monounsaturated fat and less saturated fat intake could be protective against CRCD during chemotherapy.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dieta Mediterránea / Disfunción Cognitiva Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dieta Mediterránea / Disfunción Cognitiva Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania